Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis

BACKGROUND: To assess the diagnostic and prognosis value of myocardial native T2 measurement in the distinction between Light-chain (AL) and Transthyretin (ATTR) cardiac amyloidosis (CA). METHODS: Forty-four patients with CA (24 AL; 20 ATTR) and 40 healthy subjects underwent 1.5 T cardiovascular mag...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cardiovasc Magn Reson
Autors principals: Ridouani, Fourat, Damy, Thibaud, Tacher, Vania, Derbel, Haytham, Legou, François, Sifaoui, Islem, Audureau, Etienne, Bodez, Diane, Rahmouni, Alain, Deux, Jean-François
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6097442/
https://ncbi.nlm.nih.gov/pubmed/30115079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12968-018-0478-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars